Author

Xiaowei W. Liu

Institution: Children's Oncology Group

Observed institution: Children's Oncology Group

OpenAlex ID: A5064415919

Phase 1 trial of ontuxizumab (MORAb‐004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

2018 · Robin E. Norris, Elizabeth Fox, et al. · Pediatric Blood & Cancer · 28

Works count: 1

Citation count: 28

H-index: 1

I10-index: 1